Showing 1841-1850 of 2050 results for "".
- CooperVision Announces Direct-to-Consumer Campaign Featuring Sarah Michelle Gellarhttps://modernod.com/news/coopervision-announces-direct-to-consumer-campaign-featuring-sarah-michelle-gellar/2478209/CooperVision announced popular US television actress, producer, and entrepreneur Sarah Michelle Gellar as the spokesperson for its Brilliant Futures Myopia Management Program. Brilliant Futures is built around MiSight 1 day, the first and only soft contact lens FDA-approved to slow the progressio
- Sight Sciences Announces Positive Interim Results From Trial of the OMNI Surgical System in Open-Angle Glaucomahttps://modernod.com/news/sight-sciences-announces-positive-interim-results-from-trial-of-the-omni-surgical-system-in-open-angle-glaucoma/2478205/Sight Sciences announced positive 6-month interim safety and efficacy results from a prospective, multicenter, historically controlled clinical trial of the OMNI Surgical System in open-angle glaucoma (OAG). The OMNI Surgical System is currently cleared for use for the delivery of small amounts o
- Hospital Operating Margins Down 28% Through July: Reporthttps://modernod.com/news/hospital-operating-margins-down-28-through-july-report/2478199/While there have been some early signs of recovery, uncertainty and volatility caused by the COVID-19 pandemic continued to rock hospital financials through the end of July, a new report says, according to a FierceHealthcare
- EU Wraps Up Advanced Talks With Moderna for COVID-19 Vaccine Supply Dealhttps://modernod.com/news/eu-wraps-up-advanced-talks-with-moderna-for-covid-19-vaccine-supply-deal/2478195/The European Commission said Monday that it concluded exploratory talks with Moderna for an initial purchase of 80 million doses of the company’s mRNA vaccine candidate against SARS-CoV-2. The contractual framework would also provide an option for EU member states to purchase an additional
- Neuroptika Completes Enrollment In Phase 2 Clinical Trial For Dry Eye Diseasehttps://modernod.com/news/neuroptika-completes-enrollment-in-phase-2-clinical-trial-for-dry-eye-disease/2478192/Neuroptika announced completion of enrollment in a phase 2 clinical controlled, double-masked trial of NRO-1 for the treatment of patients with dry eye disease. NRO-1 is a novel therapeutic with the potential to regenerate corneal nerves in ophthalmic diseases. “We are pleased to com
- FDA Grants EUA for Convalescent Plasma in Hospitalized COVID-19 Patientshttps://modernod.com/news/fda-grants-eua-for-convalescent-plasma-in-hospitalized-covid-19-patients/2478190/The FDA reversed itself Sunday following pressure from the White House and announced an Emergency Use Authorization for convalescent plasma as a treatment for patients who have contracted COVID-19, according to a BioSpace
- CDC Director Warns of Major Public Health Complications if Public Doesn’t Take Flu and COVID-19 Seriouslyhttps://modernod.com/news/cdc-director-warns-of-major-public-health-complications-if-public-doesnt-take-flu-and-covid-19-seriously/2478188/The Centers for Disease Control and Prevention (CDC) is scrambling to ensure there are enough supplies of—and public confidence in—the flu vaccine as fall approaches and COVID-19 is still spreading in the U.S, according to a FierceHealthcare
- Kubota Vision Receives Orphan Products Clinical Trial Grant for Stargardt Disease Treatment Candidatehttps://modernod.com/news/kubota-vision-receives-orphan-products-clinical-trials-grants-to-emixustat-for-stargardt-disease/2478187/Kubota Vision announced that the FDA Office of Orphan Products Development (OOPD) has awarded an orphan products clinical trial grant to support the ongoing phase 3 study of emixustat in Stargardt disease. Orphan product clinical trial grants support well-controlled studies that will eithe
- WSJ: Troubled COVID-19 Data System Returning to CDChttps://modernod.com/news/wsj-troubled-covid-19-data-system-returning-to-cdc/2478184/The U.S. Department of Health and Human Services is reversing course on a change to the way hospitals report critical information on the coronavirus pandemic to the government, returning the responsibility for data collection to the Centers for Disease Control and Prevention, according to a W
- Alcon Kicks Off Global Social Media Campaignhttps://modernod.com/news/alcon-kicks-off-global-social-media-campaign/2478183/Alcon kicked off a global social media campaign, “Reasons to Love Lenses,” during Contact Lens Health Week taking place August 17–21. The new campaign raises consumer awareness of the benefits of contact lens wear. The campaign also reiterates the value of prescribing contact lenses for eye care